Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ERAVACYCLINE
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
ERAVACYCLINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
07896928ZC
Molecule Type:
Small molecule
Molecular Formula:
C27H31FN4O8
Molecular Weight:
558.56
AlogP:
0.29
PSA:
193.73
HBD:
6.0
HBA:
#RotB:
5.0
Source:
BARICITINIB
(2018)
Small molecule
Tyrosine-protein kinase JAK1 inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Immune System Diseases
BARICITINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
ISP4442I3Y
Molecule Type:
Small molecule
Molecular Formula:
C16H17N7O2S
Molecular Weight:
371.43
AlogP:
1.1
PSA:
120.56
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RIFAMYCIN SODIUM
(2018)
Small molecule
DNA-directed RNA polymerase inhibitor
Unknown
Approved
Diarrhea
RIFAMYCIN SODIUM
×
Maximum Phase:
4
First Approval:
2018
UNII:
32086GS35Z
Molecule Type:
Small molecule
Molecular Formula:
C37H46NNaO12
Molecular Weight:
719.76
AlogP:
4.75
PSA:
201.31
HBD:
6.0
HBA:
#RotB:
2.0
Source:
PLAZOMICIN
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
PLAZOMICIN
×
Maximum Phase:
4
First Approval:
2018
UNII:
LYO9XZ250J
Molecule Type:
Small molecule
Molecular Formula:
C25H48N6O10
Molecular Weight:
592.69
AlogP:
-5.36
PSA:
269.29
HBD:
11.0
HBA:
#RotB:
13.0
Source:
LORLATINIB
(2018)
Small molecule
ALK tyrosine kinase receptor inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Lymphoma; Neoplasms
LORLATINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
OSP71S83EU
Molecule Type:
Small molecule
Molecular Formula:
C21H19FN6O2
Molecular Weight:
406.42
AlogP:
2.8
PSA:
110.06
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ERAVACYCLINE DIHYDROCHLORIDE
(2018)
Small molecule
Bacterial 70S ribosome inhibitor
INTRAVENOUS
Approved
Intraabdominal Infections
ERAVACYCLINE DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
WK1NMH89VJ
Molecule Type:
Small molecule
Molecular Formula:
C27H33Cl2FN4O8
Molecular Weight:
631.49
AlogP:
0.29
PSA:
193.73
HBD:
6.0
HBA:
#RotB:
5.0
Source:
LOFEXIDINE HYDROCHLORIDE
(2018)
Small molecule
Adrenergic receptor alpha-2 agonist
ORAL
Approved
Substance Withdrawal Syndrome
LOFEXIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
V47G1SDI1B
Molecule Type:
Small molecule
Molecular Formula:
C11H13Cl3N2O
Molecular Weight:
295.6
AlogP:
2.76
PSA:
33.62
HBD:
1.0
HBA:
#RotB:
3.0
Source:
OMADACYCLINE TOSYLATE
(2018)
Small molecule
Bacterial 70S ribosome inhibitor
INTRAVENOUS; ORAL
Approved
Pneumonia, Bacterial; Skin Diseases, Bacterial
OMADACYCLINE TOSYLATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
5658Y89YCD
Molecule Type:
Small molecule
Molecular Formula:
C36H48N4O10S
Molecular Weight:
728.87
AlogP:
1.32
PSA:
176.66
HBD:
6.0
HBA:
#RotB:
6.0
Source:
OMADACYCLINE
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
OMADACYCLINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
090IP5RV8F
Molecule Type:
Small molecule
Molecular Formula:
C29H40N4O7
Molecular Weight:
556.66
AlogP:
1.32
PSA:
176.66
HBD:
6.0
HBA:
#RotB:
6.0
Source:
SARECYCLINE
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
SARECYCLINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
94O110CX2E
Molecule Type:
Small molecule
Molecular Formula:
C24H29N3O8
Molecular Weight:
487.51
AlogP:
0.11
PSA:
173.86
HBD:
5.0
HBA:
#RotB:
5.0
Source:
MIGALASTAT
(2018)
Small molecule
Alpha-galactosidase A stabiliser
Unknown
Approved
Unknown
MIGALASTAT
×
Maximum Phase:
4
First Approval:
2018
UNII:
C4XNY919FW
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO4
Molecular Weight:
163.17
AlogP:
-2.97
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
1.0
Source:
E133
(2019)
Small molecule
Unknown
Unknown
Approved
Unknown
E133
×
Maximum Phase:
3
First Approval:
2019
UNII:
H3R47K3TBD
Molecule Type:
Small molecule
Molecular Formula:
C47H49N3O7S2
Molecular Weight:
832.06
AlogP:
9.31
PSA:
139.08
HBD:
2.0
HBA:
#RotB:
15.0
Source:
ESKETAMINE
(2019)
Small molecule
Glutamate [NMDA] receptor negative allosteric modulator
Unknown
Approved
Depressive Disorder
ESKETAMINE
×
Maximum Phase:
4
First Approval:
2019
UNII:
50LFG02TXD
Molecule Type:
Small molecule
Molecular Formula:
C13H16ClNO
Molecular Weight:
237.73
AlogP:
2.9
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FERRIC MALTOL
(2019)
Small molecule
Supplement
ORAL
Approved
Unknown
FERRIC MALTOL
×
Maximum Phase:
4
First Approval:
2019
UNII:
MA10QYF1Z0
Molecule Type:
Small molecule
Molecular Formula:
C18H15FeO9
Molecular Weight:
431.15
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PITOLISANT HYDROCHLORIDE
(2019)
Small molecule
Histamine H3 receptor inverse agonist
ORAL
Approved
Disorders of Excessive Somnolence; Narcolepsy
PITOLISANT HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2019
UNII:
YV33CH63HI
Molecule Type:
Small molecule
Molecular Formula:
C17H27Cl2NO
Molecular Weight:
332.32
AlogP:
4.17
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
8.0
Source:
TAFAMIDIS
(2019)
Small molecule
Transthyretin stabiliser
ORAL
Approved
Amyloidosis; Amyloidosis, Familial; Cardiomyopathies
TAFAMIDIS
×
Maximum Phase:
4
First Approval:
2019
UNII:
8FG9H9D31J
Molecule Type:
Small molecule
Molecular Formula:
C14H7Cl2NO3
Molecular Weight:
308.12
AlogP:
4.5
PSA:
63.33
HBD:
1.0
HBA:
#RotB:
2.0
Source:
AIR POLYMER-TYPE A
(2019)
Small molecule
Ultrasound contrast agent
Unknown
Approved
Unknown
AIR POLYMER-TYPE A
×
Maximum Phase:
4
First Approval:
2019
UNII:
WLT3PF2KX0
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BRILLIANT BLUE G
(2019)
Small molecule
Membrane staining aid in ophthalmic surgery
Unknown
Approved
Unknown
BRILLIANT BLUE G
×
Maximum Phase:
4
First Approval:
2019
UNII:
M1ZRX790SI
Molecule Type:
Small molecule
Molecular Formula:
C47H48N3NaO7S2
Molecular Weight:
854.04
AlogP:
9.31
PSA:
139.08
HBD:
2.0
HBA:
#RotB:
15.0
Source:
PEXIDARTINIB
(2019)
Small molecule
Macrophage colony stimulating factor receptor inhibitor
Unknown
Approved
Neoplasms
PEXIDARTINIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
6783M2LV5X
Molecule Type:
Small molecule
Molecular Formula:
C20H15ClF3N5
Molecular Weight:
417.82
AlogP:
5.23
PSA:
66.49
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PITOLISANT
(2019)
Small molecule
Histamine H3 receptor inverse agonist
Unknown
Approved
Unknown
PITOLISANT
×
Maximum Phase:
4
First Approval:
2019
UNII:
4BC83L4PIY
Molecule Type:
Small molecule
Molecular Formula:
C17H26ClNO
Molecular Weight:
295.85
AlogP:
4.17
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
8.0
Source:
ZANUBRUTINIB
(2019)
Small molecule
Tyrosine-protein kinase BTK inhibitor
Unknown
Approved
Lymphoma, Mantle-Cell; Neoplasms
ZANUBRUTINIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
AG9MHG098Z
Molecule Type:
Small molecule
Molecular Formula:
C27H29N5O3
Molecular Weight:
471.56
AlogP:
4.22
PSA:
102.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ISTRADEFYLLINE
(2019)
Small molecule
Adenosine A2a receptor antagonist
ORAL
Approved
Parkinson Disease
ISTRADEFYLLINE
×
Maximum Phase:
4
First Approval:
2019
UNII:
2GZ0LIK7T4
Molecule Type:
Small molecule
Molecular Formula:
C20H24N4O4
Molecular Weight:
384.44
AlogP:
2.12
PSA:
80.28
HBD:
0.0
HBA:
#RotB:
6.0
Source:
FLUORODOPA F 18
(2019)
Small molecule
Diagnostic agent
Unknown
Approved
Unknown
FLUORODOPA F 18
×
Maximum Phase:
4
First Approval:
2019
UNII:
2C598205QX
Molecule Type:
Small molecule
Molecular Formula:
C9H10FNO4
Molecular Weight:
214.18
AlogP:
0.19
PSA:
103.78
HBD:
4.0
HBA:
#RotB:
3.0
Source:
SIPONIMOD FUMARATE
(2019)
Small molecule
Sphingosine 1-phosphate receptor Edg-1 agonist
Unknown
Approved
Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting
SIPONIMOD FUMARATE
×
Maximum Phase:
4
First Approval:
2019
UNII:
Z7G02XZ0M6
Molecule Type:
Small molecule
Molecular Formula:
C62H74F6N4O10
Molecular Weight:
1149.28
AlogP:
6.77
PSA:
62.13
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TAFAMIDIS MEGLUMINE
(2019)
Small molecule
Transthyretin stabiliser
ORAL
Approved
Amyloidosis; Amyloidosis, Familial; Cardiomyopathies
TAFAMIDIS MEGLUMINE
×
Maximum Phase:
4
First Approval:
2019
UNII:
ZU7CF08A1A
Molecule Type:
Small molecule
Molecular Formula:
C21H24Cl2N2O8
Molecular Weight:
503.34
AlogP:
4.5
PSA:
63.33
HBD:
1.0
HBA:
#RotB:
2.0
Source:
DIROXIMEL FUMARATE
(2019)
Small molecule
Kelch-like ECH-associated protein 1 inhibitor
Unknown
Approved
Immune System Diseases; Multiple Sclerosis
DIROXIMEL FUMARATE
×
Maximum Phase:
4
First Approval:
2019
UNII:
K0N0Z40J3W
Molecule Type:
Small molecule
Molecular Formula:
C11H13NO6
Molecular Weight:
255.23
AlogP:
-0.59
PSA:
89.98
HBD:
0.0
HBA:
#RotB:
5.0
Source:
VOXELOTOR
(2019)
Small molecule
Hemoglobin HbA positive modulator
Unknown
Approved
Anemia, Sickle Cell
VOXELOTOR
×
Maximum Phase:
4
First Approval:
2019
UNII:
3ZO554A4Q8
Molecule Type:
Small molecule
Molecular Formula:
C19H19N3O3
Molecular Weight:
337.38
AlogP:
3.62
PSA:
77.24
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PRETOMANID
(2019)
Small molecule
Unknown
ORAL
Approved
Tuberculosis; Tuberculosis, Pulmonary
PRETOMANID
×
Maximum Phase:
4
First Approval:
2019
UNII:
2XOI31YC4N
Molecule Type:
Small molecule
Molecular Formula:
C14H12F3N3O5
Molecular Weight:
359.26
AlogP:
2.67
PSA:
88.65
HBD:
0.0
HBA:
#RotB:
5.0
Source:
SIPONIMOD
(2019)
Small molecule
Sphingosine 1-phosphate receptor Edg-1 agonist
Unknown
Approved
Immune System Diseases
SIPONIMOD
×
Maximum Phase:
4
First Approval:
2019
UNII:
RR6P8L282I
Molecule Type:
Small molecule
Molecular Formula:
C29H35F3N2O3
Molecular Weight:
516.6
AlogP:
6.77
PSA:
62.13
HBD:
1.0
HBA:
#RotB:
9.0
Source:
LEVAMLODIPINE
(2019)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
LEVAMLODIPINE
×
Maximum Phase:
4
First Approval:
2019
UNII:
0P6NLP6806
Molecule Type:
Small molecule
Molecular Formula:
C20H25ClN2O5
Molecular Weight:
408.88
AlogP:
2.27
PSA:
99.88
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TRIFAROTENE
(2019)
Small molecule
Retinoic acid receptor gamma agonist
TOPICAL
Approved
Acne Vulgaris
TRIFAROTENE
×
Maximum Phase:
4
First Approval:
2019
UNII:
0J8RN2W0HK
Molecule Type:
Small molecule
Molecular Formula:
C29H33NO4
Molecular Weight:
459.59
AlogP:
5.99
PSA:
70.0
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ESKETAMINE HYDROCHLORIDE
(2019)
Small molecule
Glutamate [NMDA] receptor negative allosteric modulator
NASAL
Approved
Depressive Disorder, Major
ESKETAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2019
UNII:
L8P1H35P2Z
Molecule Type:
Small molecule
Molecular Formula:
C13H17Cl2NO
Molecular Weight:
274.19
AlogP:
2.9
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ALPELISIB
(2019)
Small molecule
PI3-kinase p110-alpha subunit inhibitor
ORAL
Approved
Breast Neoplasms; Neoplasms
ALPELISIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
08W5N2C97Q
Molecule Type:
Small molecule
Molecular Formula:
C19H22F3N5O2S
Molecular Weight:
441.48
AlogP:
3.84
PSA:
101.21
HBD:
2.0
HBA:
#RotB:
4.0
Source:
CEFIDEROCOL SULFATE TOSYLATE
(2019)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Approved
Pneumonia, Bacterial; Urinary Tract Infections
CEFIDEROCOL SULFATE TOSYLATE
×
Maximum Phase:
4
First Approval:
2019
UNII:
TTP8LBP45D
Molecule Type:
Small molecule
Molecular Formula:
C118H138Cl3N21O47S11
Molecular Weight:
3061.6
AlogP:
-0.18
PSA:
256.9
HBD:
6.0
HBA:
#RotB:
13.0
Source:
LEFAMULIN ACETATE
(2019)
Small molecule
Bacterial 70S ribosome inhibitor
INTRAVENOUS; ORAL
Approved
Pneumonia, Bacterial
LEFAMULIN ACETATE
×
Maximum Phase:
4
First Approval:
2019
UNII:
HDN0B924X4
Molecule Type:
Small molecule
Molecular Formula:
C30H49NO7S
Molecular Weight:
567.79
AlogP:
3.87
PSA:
109.85
HBD:
3.0
HBA:
#RotB:
5.0
Source:
ERDAFITINIB
(2019)
Small molecule
Fibroblast growth factor receptor inhibitor
ORAL
Approved
Carcinoma, Transitional Cell; Neoplasms; Urinary Bladder Neoplasms
ERDAFITINIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
890E37NHMV
Molecule Type:
Small molecule
Molecular Formula:
C25H30N6O2
Molecular Weight:
446.56
AlogP:
4.18
PSA:
77.33
HBD:
1.0
HBA:
#RotB:
9.0
Source:
1
2
…
69
70
71
72
73
74
75
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA